Funding arb · Price arb / RWA
| Leg | Exchange | Price | Fund. /8h | Each payment | Next in | OI | Vol 24h | Lev | |
|---|---|---|---|---|---|---|---|---|---|
| LONG | 643.00 | +0.0008 | pay 0.0001% / 1h | 22m 36s | $247K | $13K | — | Long AZverse | |
| SHORT | 640.22 | +0.0033 | get 0.0004% / 1h | 22m 36s | $516 | $241K | 25x | Short Injective |
Price gap−0.433%59s
Funding gap+0.0025% /8h
Funding pays +$1 a day on $10k, but the gap is 0.148% under its 7d average: −$15 if it goes back, about 19 days of funding. At the last 7 days' pace that is about 3.4 days.
If you open now and hold
on $10k a leg · figures of the last 7D, not a forecastFunding+$3+0.0025% /8h now · paid +0.030% over the last 17 hours (all we have)
Price—spread −0.433%59s now · prices read too far apart to compare
Costsno datano order book for AZverse
Result, before costs—no pointsneeds both prices read together
Price and funding
1h · historyEntry / Exit
Price spread
Prices
Fundingper 8h
ENTRY / EXIT · 7D
Entry now—
Entry average—
Best entry—
Exit now—
Exit average—
Best exit—
Exit free—
PRICE SPREAD · 7D
Now−0.433%
Average—
Range—
Wider than now—
FUNDING SPREAD · 7D
Average /8h—
Highest—
Lowest—
Paid you—
Where the spread has been, last 7D▾
share of time at each level
Funding on every exchange
/8hMETA on 44 exchanges
lowest funding firstBefore you open
2 ok · 2 to watch- Note: Order book unknown—No order-book sample for AZverse: its slippage is not counted.
- Note: Margin at max leverage— + $400AZverse —, Injective 25x. Keep about 2× this so a sharp move doesn’t liquidate one leg.
- OK: Same payment interval1h / 1hBoth legs pay at the same time.Next 24h at the current rates, on $10k a leg: +$0.76Long AZverse: 24 payments, −$0.24; short Injective: 24 payments, +$1.00.
- Watch: Prices read 59 s apart−0.433% vs −0.285%Part of this gap may be the market moving.
- Watch: Short leg is thinner$516 vs $247K OIInjective sets your exit cost. Check its book before closing.
- Note: No points program—Neither exchange runs points right now.
- OK: No KYC on either legAZverse No · Injective NoBoth exchanges let you trade without ID.
Profit calculator
both legs, in and outPosition, each legHold forOrdersPrice spreadFunding rate
Funding earned+0.0146%/8h × 21 periods+$30.72
Price spreadprices read too far apart to compare—
Slippage, 4 ordersno data for AZverse—
Fee AZverse bp × 2 orders−$12.00
Fee Injective bp × 2 orders−$0.02
Net, fees only · 7 days · $10k+$18.70
price spread not counted: prices read too far apartCosts to cover0.120%Break-even2.7 days
Slippage: AZverse: no order-book sample; Injective: live order book, 32 min agoCost to enter
taker + slippage from mid, one sideBUY · LONGAZverse—————
SELL · SHORTInjective42.8042.8 bp−$43doesn’t fitdoesn’t fitdoesn’t fit
Closing costs about the same again.
AZverse: no data.
| 10-23 12:16 | SoDEX | Points | 🎉 Happy Points Day! Layer1 Season Week 7 points are LIVE! 🚀 SoDEX Open Interest Hits $309.53M! 🔥 Another milestone unlocked! From $270M to over $309M — thank you to our growing trading community! 🧡 ⚡ Week 8 Bonus: Trade ZEC-USD, NEAR-USD, TSLA-USD, META-USD, CL-USD, SPCX-USD, QNT-USD perps to earn 1.2× SoPoints on trading volume! 🎁 Check your points 👉 @sodex_official on X ↗ |
| 10-23 12:15 | SoDEX | Points | 🎉 Happy Points Day! Layer1 Season Week 7 points are LIVE! 🚀 SoDEX Open Interest Hits $309.53M! 🔥 Another milestone unlocked! From $270M to over $309M — thank you to our growing trading community! 🧡 ⚡ Week 8 Bonus: Trade ZEC-USD, NEAR-USD, TSLA-USD, META-USD, CL-USD, SPCX-USD, QNT-USD perps to earn 1.2× SoPoints on trading volume! 🎁 Check your points 👉 @sodex_official on X ↗ |
| 10-23 08:35 | Phemex | Other | $META beat on revenue. Then spent its way to −7%. Wall Street's closed. We're not. Buy the beat 🟢 or fade the spend 🔴? 👇 @Phemex_official on X ↗ |
| 10-22 22:57 | Injective | Token | The second-ever Injective Stockdrop kicks off next week. Anyone who participated in the $INJ BuyBack yesterday has a chance to earn a tokenized stock on Solana. Here are just a few of the tokenized stocks that you could get: $AMC $SNAP $GLXY $HIMS $SMCI $RKLB $CRCL $INTC $MSTR $SPCX $COIN $NVDA $AAPL $TSLA $META $MU $SNDK More ▇▇▇▇ and ▇▇ @injective on X ↗ |
| 10-22 13:30 | Vest Markets | Other | Trade $META post-earnings volatility with a Vest Capital funded account. Access up to $50k in trading capital at: @VestExchange on X ↗ |
| 10-22 13:30 | Vest Markets | Other | $META reported Q3 revenue of $64.60B, up 26% YoY, versus the $63.3B expected, with GAAP EPS of $3.83. At the open, $META is down close to 3%, with the $73B-$76B Q4 revenue outlook weighed against the $175B-$179B 2026 expense outlook. → Revenue: $64.60B vs. $63.3B consensus, versus Meta's $61B-$64B outlook → EPS: $3.83 GAAP vs. $3.57 expected, or $7.40 excluding a $9.89B legal charge → Capex: $34.91B, versus $31.08B in Q2 → Q4 revenue outlook: $73B-$76B $META also plans non-voting Class C stock from January 19, 2027, with a dividend expected to work as a 2-for-1 split and no change to shareholder voting power. @VestExchange on X ↗ |

SoDEX
Phemex